This is a synthetic peptide designed for use in combination with anti- FLII Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
FLII
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
FLII
(Flightless I Homolog (FLII))
Synonyme
FLI Peptide, FLIL Peptide, Fli1 Peptide, 3632430F08Rik Peptide, Fliih Peptide, im:7141769 Peptide, DKFZp459O043 Peptide, flightless Peptide, FLII, actin remodeling protein Peptide, flightless I actin binding protein Peptide, protein flightless-1 homolog Peptide, FLII, actin remodeling protein S homeolog Peptide, Protein flightless-1 homolog Peptide, FLII Peptide, Flii Peptide, flii Peptide, LOC585336 Peptide, LOC100640615 Peptide, flii.S Peptide, fli-1 Peptide
Hintergrund
This gene encodes a protein with a gelsolin-like actin binding domain and an N-terminal leucine-rich repeat-protein protein interaction domain. The protein is similar to a Drosophila protein involved in early embryogenesis and the structural organization of indirect flight muscle. The gene is located within the Smith-Magenis syndrome region on chromosome 17.